These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 19476724)

  • 21. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
    Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
    Trials; 2013 Jul; 14():198. PubMed ID: 23829417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the GlucoWatch biographer in children with type 1 diabetes.
    Chase HP; Roberts MD; Wightman C; Klingensmith G; Garg SK; Van Wyhe M; Desai S; Harper W; Lopatin M; Bartkowiak M; Tamada J; Eastman RC
    Pediatrics; 2003 Apr; 111(4 Pt 1):790-4. PubMed ID: 12671113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical use of continuous glucose monitoring system in gestational diabetes mellitus and type 2 diabetes complicated with pregnancy].
    Song Y; Yang H
    Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):579-83. PubMed ID: 25354857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
    Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
    BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial.
    Zhou Y; Deng H; Liu H; Yang D; Xu W; Yao B; Yan J; Weng J
    BMJ Open; 2020 Dec; 10(12):e039400. PubMed ID: 33277281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial.
    Wild SH; Hanley J; Lewis SC; McKnight JA; McCloughan LB; Padfield PL; Parker RA; Paterson M; Pinnock H; Sheikh A; McKinstry B
    PLoS Med; 2016 Jul; 13(7):e1002098. PubMed ID: 27458809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does self monitoring of blood glucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education? The DESMOND SMBG randomised controlled trial protocol.
    Dallosso HM; Eborall HC; Daly H; Martin-Stacey L; Speight J; Realf K; Carey ME; Campbell MJ; Dixon S; Khunti K; Davies MJ; Heller S
    BMC Fam Pract; 2012 Mar; 13():18. PubMed ID: 22416896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial.
    Nanditha A; Thomson H; Susairaj P; Srivanichakorn W; Oliver N; Godsland IF; Majeed A; Darzi A; Satheesh K; Simon M; Raghavan A; Vinitha R; Snehalatha C; Westgate K; Brage S; Sharp SJ; Wareham NJ; Johnston DG; Ramachandran A
    Diabetologia; 2020 Mar; 63(3):486-496. PubMed ID: 31919539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
    Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
    Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial.
    House A; Bryant L; Russell AM; Wright-Hughes A; Graham L; Walwyn R; Wright JM; Hulme C; O'Dwyer JL; Latchford G; Meer S; Birtwistle JC; Stansfield A; Ajjan R; Farrin A
    Health Technol Assess; 2018 May; 22(26):1-328. PubMed ID: 29845932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and piloting of an acceptability questionnaire for continuous glucose monitoring devices.
    Steed L; Cooke D; Hurel SJ; Newman SP
    Diabetes Technol Ther; 2008 Apr; 10(2):95-101. PubMed ID: 18260772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flash glucose monitoring with the FreeStyle Libre 2 compared with self-monitoring of blood glucose in suboptimally controlled type 1 diabetes: the FLASH-UK randomised controlled trial protocol.
    Wilmot EG; Evans M; Barnard-Kelly K; Burns M; Cranston I; Elliott RA; Gkountouras G; Kanumilli N; Krishan A; Kotonya C; Lumley S; Narendran P; Neupane S; Rayman G; Sutton C; Taxiarchi VP; Thabit H; Leelarathna L
    BMJ Open; 2021 Jul; 11(7):e050713. PubMed ID: 34261691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.
    Tanenberg R; Bode B; Lane W; Levetan C; Mestman J; Harmel AP; Tobian J; Gross T; Mastrototaro J
    Mayo Clin Proc; 2004 Dec; 79(12):1521-6. PubMed ID: 15595336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial.
    Dobson R; Whittaker R; Jiang Y; Maddison R; Shepherd M; McNamara C; Cutfield R; Khanolkar M; Murphy R
    BMJ; 2018 May; 361():k1959. PubMed ID: 29773539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of metabolic control in patients with diabetes treated with insulin using Contour USB and A1cNow+ devices (COMET study).
    Vinagre I; Álvarez P; García N; Roura G; Conget I;
    Endocrinol Nutr; 2015 Oct; 62(8):384-90. PubMed ID: 26391507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study.
    Ludvigsson J; Hanas R
    Pediatrics; 2003 May; 111(5 Pt 1):933-8. PubMed ID: 12728068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
    Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
    Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.